<DOC>
	<DOCNO>NCT00375544</DOCNO>
	<brief_summary>This Phase I study conducted examine efficacy Light Sciences LLC ( LSLLC ) phototherapy device home ( self ) treatment knee osteoarthritis ( OA ) .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy Low Level Light Device Patients With Knee Osteoarthritis</brief_title>
	<detailed_description>This Phase I study conducted examine efficacy Light Sciences LLC ( LSLLC ) phototherapy device home ( self ) - treatment knee osteoarthritis ( OA ) . Clinical efficacy assess evaluate level report pain , include use analgesic , various measure functional improvement , clinical symptomology three week period daily treatment . Durability clinical response twelve week follow therapy also examine . In addition , device safety assess . As early stage-prototype device , subject input regard usability device seek . Subjects require achieve three week wash-out OA therapy prior start phototherapy . Acetaminophen allow time . During three week active treatment twelve week follow-up period , subject require refrain acetaminophen well OA therapy . However , subject encourage speak investigator symptom become difficult manage . In addition clinical assessment , subject require keep daily diary . The clinical objective study meet least five ten subject report decrease pain score improvement osteoarthritis index . While minimum safety issue expect , occurrence skin change area expose device carefully monitor .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Male female At least age 40 year Community ambulator without orthoses Knee circumference range 35.5 43 cm . ( 1417 inch ) Moderate OA accord clinician judgment , and/or Radiographic evidence knee OA KellgrenLawrence Grade II III one knee . Exercise induce pain , subject exercise , pain result activity daily live , least 3 month duration Knee pain great 1 VAS within last 24 hour evaluation . Fitzpatrick type I , II , III skin . ( light darker Caucasian/light Asian . ) ( Selection avoids excessive light absorption epidermis ) Understands agree comply study procedure include daily treatment followup visit Able understand voluntarily willing sign inform consent form study Pregnant nursing , ability become pregnant use accepted form birth control Other cause kneerelated pain ( e.g . hip OA , arterial insufficiency , etc ) rule physical examination Fitzpatrick type IV , V , VI skin . ( Mediterranean/Asian/Hispanic darkskinned black ) Any active Cancer History melanoma limb evaluate study Uncontrolled diabetes mellitus Untreated hypertension Skin condition would interfere device use/placement Psychotic disorder ( ) , dementia , mental retardation , organic mental disorder ( subject mentally physically able personally consent participation study eligible ) Any ( include acute ) condition , opinion investigator , likely cause noncompliance significantly impact treatment outcome . Subject receive intra peri articular steroid , , injection therapy within 6 month prior enrollment study . Enrolled clinical trial within last 6 week enrollment another clinical trial participation trial . Subjects expect able comply follow restriction course participation study , include washout period : Prescription NSAID use prohibit Use photosensitize drug prohibit Physiotherapy prohibit treatment limb ( ) evaluate study . Glucosamine use prohibit</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Laser Therapy , Low-Level</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Phototherapy</keyword>
	<keyword>Osteoarthritis , knee</keyword>
	<keyword>Light-emitting diode</keyword>
</DOC>